Endo ERN
Find an expert
Endo ERN
Search
  • Rare Endocrine Conditions

    Endocrine Conditions

    Endo-ERN is focused on 8 main thematic groups (MTGs) which cover rare and/or complex endocrine conditions

    Go to overview

    Categories

    • MTG1Adrenal
    • MTG2Disorders of Calcium & Phosphate Homeostasis
    • MTG3Genetic Disorders of Glucose & Insulin Homeostasis
    • MTG4Genetic Endocrine Tumour Syndromes
    • MTG5Growth & Genetic Obesity Syndromes
    • MTG6Hypothalamic and Pituitary Conditions
    • MTG7Sex Development & Maturation
    • MTG8Thyroid
  • About Us

    About Us

    Endo-ERN is a network of 100+ Reference Centres (RCs) in 27 EU member states+Norway that offers access to clinical experts for patients with rare endocrine conditions.  

    Go to overview

    Who we are

    • About Endo-ERN
    • What we do
    • Reference centres
    • Work packages
    • Project team

    Information

    • Events
    • FAQ
    • Newsletter
    • Contact
    • ERNs
  • For Professionals

    For Professionals

    Endo-ERN is the network for rare endocrine conditions providing healthcare professionals with access to a variety of resources to support patient care.  

    Our Network

    • About Endo-ERN
    • Find a Reference Centre

    Research

    • Registries
    • Publications
    • Clinical Trials

    Support Tools

    • Virtual Consultations
    • Guidelines
    • COVID-19

    Training & Education

    • Webinars
    • Exchange Programme
  • For Members

    For Members

    If you work at a member institution this page will help with your Endo-ERN contributions.  

    Go to overview

    Quick Links

    • Cite Endo-ERN
    • CPMS 2.0
    • GA2026
    • The Journal

    Evaluation

    • Continuous Monitoring Exercise
    • 5-year evaluation
    • HCP Performance System

    Network Participation

    • Event Endorsement
    • Member Survey
    • Webinar Planning
    • MTG Representatives

    Membership Management

    • Update Member Contacts
    • Request Disease Area Expansion
    • Termination Policy
  • For Patients

    For Patients

    Access to rare disease expertise without the need to travel is a core ERN objective.  Our ePAGs contribute to all Endo-ERN activities.  

    Go to overview

    Patient information

    • What are European Reference Networks?
    • Cross-border healthcare
    • Rare endocrine conditions
    • Patient materials

    ePAG information

    • European Patient Advocacy Groups
    • Patient representatives
    • How to become an Endo-ERN ePAG
  • Search
  • Rare Endocrine Conditions
  • About Us
  • For Professionals
  • For Members
  • For Patients
  • Search
  • Rare Endocrine Conditions
  • About Us
  • For Professionals
  • For Members
  • For Patients
  • Search
Endo ERN
Find an expert
Search
/ Publications Overview / Publications Database

Endo-ERN Publications Database

RDD IssuesBack to Publications Overview

Filter list of publications

890 publication(s) found matching the search criteria

Characteristics of specialists treating hypothyroid patients: the “THESIS” collaborative


Author(s): Žarković M, Attanasio R, Nagy EV, Negro R, Papini E, Perros P, Cohen CA, Akarsu E, Alevizaki M, Ayvaz G, Bednarczuk T, Berta E, Bodor M, Borissova AM, Boyanov M, Buffet C, Burlacu M, Ćirić J, Díez JJ, Dobnig H, Fadeyev V, Field BCT, Fliers E, Frølich JS, Führer D, Galofré JC, Hakala T, Jiskra J, Kopp P, Krebs M, Kršek M, Kužma M, Lantz M, Lazúrová I, Leenhardt L, Luchytskiy V, McGowan A, Melo M, Metso S, Moran C, Morgunova T, Mykola T, Beleslin BN, Niculescu DA, Perić B, Planck T, Poiana C, Puga FM, Robenshtok E, Rosselet P, Ruchala M, Riis KR, Shepelkevich A, Unuane D, Vardarli I, Visser WE, Vrionidou A, Younes YR, Yurenya E, Hegedüs L
Affiliated Institution / ERN: University Hospital Essen ;
Condition / Disease: hypothyroidism
Publication: Frontiers in Endocrinology v14 Year: 2023 ORPHAcode / other:
DOI: 10.3389/fendo.2023.1225202 Keywords: Europe,endocrinologists,healthcare delivery,hypothyroidism,questionnaire
MTG8

Gonadotropin-Releasing Hormone Receptor (GnRHR) and Hypogonadotropic Hypogonadism


Author(s): Fanis P, Neocleous V, Papapetrou I, Phylactou LA, Skordis N
Affiliated Institution / ERN: Cyprus Institute of Neurology and Genetics ;
Condition / Disease: Normosmic congenital hypogonadotropic hypogonadism
Publication: International Journal of Molecular Sciences v24.21 p15965 Year: 2023 ORPHAcode / other: ORPHA432
DOI: 10.3390/ijms242115965 Keywords: GnRH,GnRHR,HPG axis,gonadotropes,hypogonadotropic hypogonadism,pituitary
MTG7

Gonadotropin-Releasing Hormone Receptor (GnRHR) and Hypogonadotropic Hypogonadism


Author(s): Fanis P, Neocleous V, Papapetrou I, Phylactou LA, Skordis N
Affiliated Institution / ERN: Cyprus Institute of Neurology and Genetics ;
Condition / Disease: hypogonadotropic hypogonadism; pituitary
Publication: International Journal of Molecular Sciences v24.21 p15965 Year: 2023 ORPHAcode / other: ORPHA478; ORPHA432
DOI: 10.3390/ijms242115965 Keywords: GnRH,GnRHR,HPG axis,gonadotropes,hypogonadotropic hypogonadism,pituitary
MTG6

Consensus on criteria for acromegaly diagnosis and remission


Author(s): Giustina A, Biermasz N, Casanueva FF, Fleseriu M, Mortini P, Strasburger C, van der Lely AJ, Wass J, Melmed S, Banfi G, Barkan A, Beckers A, Bidlingmaier M, Boguszewski C, Brue T, Buchfelder M, Chanson P, Chiloiro S, Colao A, Coopmans E, Esposito D, Ferone D, Frara S, Gadelha M, Geer EB, Ghigo E, Greenman Y, Gurnell M, Ho K, Ioachimescu A, Johannsson G, Jørgensen JO, Kaiser UB, Karavitaki N, Katznelson L, Lamberts S, Losa M, Luger A, Luque R, Maffei P, Marazuela M, Neggers S, Pereira A, Persani L, Petersenn S, Reincke M, Salvatori R, Samson SN, Schilbach K, Shimon I, Tsagarakis S, Zatelli MC
Affiliated Institution / ERN: IRCCS Auxologico Italian Institute - Milan ;
Condition / Disease: Acromegaly
Publication: Pituitary doi:10.1007/s11102-023-01360-1 Year: 2023 ORPHAcode / other: ORPHA963
DOI: 10.1007/s11102-023-01360-1 Keywords: Acromegaly,Assays,Diagnosis,Growth hormone,Insulin-like growth factor I,Remission criteria
MTG6

Consensus on criteria for acromegaly diagnosis and remission


Author(s): Giustina A, Biermasz N, Casanueva FF, Fleseriu M, Mortini P, Strasburger C, van der Lely AJ, Wass J, Melmed S, Banfi G, Barkan A, Beckers A, Bidlingmaier M, Boguszewski C, Brue T, Buchfelder M, Chanson P, Chiloiro S, Colao A, Coopmans E, Esposito D, Ferone D, Frara S, Gadelha M, Geer EB, Ghigo E, Greenman Y, Gurnell M, Ho K, Ioachimescu A, Johannsson G, Jørgensen JO, Kaiser UB, Karavitaki N, Katznelson L, Lamberts S, Losa M, Luger A, Luque R, Maffei P, Marazuela M, Neggers S, Pereira A, Persani L, Petersenn S, Reincke M, Salvatori R, Samson SN, Schilbach K, Shimon I, Tsagarakis S, Zatelli MC
Affiliated Institution / ERN: AOU Federico II - Naples ; San Raffaele hospital - Milan ; Erasmus MC: University Medical Center Rotterdam ; Charité Universitätsmedizin Berlin ;
Condition / Disease: Acromegaly
Publication: Pituitary doi:10.1007/s11102-023-01360-1 Year: 2023 ORPHAcode / other: ORPHA963
DOI: 10.1007/s11102-023-01360-1 Keywords: Acromegaly,Assays,Diagnosis,Growth hormone,Insulin-like growth factor I,Remission criteria
MTG6

Evaluation of Ex Vivo Adrenocorticotropic Hormone Responsiveness of Human Fetal Testis


Author(s): Schröder MAM, Greenald D, Lodewijk R, van Herwaarden AE, Span PN, Sweep FCGJ, Mitchell RT, Claahsen-van der Grinten HL
Affiliated Institution / ERN: Radboud University Medical Centre Nijmegen ;
Condition / Disease: Congenital Adrenal Hyperplasia
Publication: Endocrinology v164.12 Year: 2023 ORPHAcode / other: ORPHA418
DOI: 10.1210/endocr/bqad165 Keywords: adrenocorticotropic hormone,congenital adrenal hyperplasia,human fetal testis,testicular adrenal rest tumors
MTG1

Expected Basal Insulin Requirement During Continuous Subcutaneous Insulin Infusion Therapy by Age Group, Sex, and Body Mass Index, Based on 25,718 Young People with Type 1 Diabetes in the DPV Registry


Author(s): Biester T, Eckert A, Becker M, Boettcher C, Golembowski S, Heidtmann B, Klinkert C, Müther S, Rami-Merhar B, Holl RW
Affiliated Institution / ERN: Centre Hospitalier de Luxembourg ;
Condition / Disease: diabetes type 1
Publication: Diabetes Technology & Therapeutics v25.11 p774-781 Year: 2023 ORPHAcode / other:
DOI: 10.1089/dia.2023.0283 Keywords: Automated insulin dosage,Basal rate,Continuous subcutaneous insulin infusion,Insulin pump,Type 1 diabetes
MTG3

Changes in bone and mineral homeostasis after short-term androgen deprivation therapy with or without androgen receptor signalling inhibitor – substudy of a single-centre, double blind, randomised, placebo-controlled phase 2 trial


Author(s): David K, Devos G, Narinx N, Antonio L, Devlies W, Deboel L, Schollaert D, Eisenhauer A, Cavalier E, Vanderschueren D, Claessens F, Joniau S, Decallonne B
Affiliated Institution / ERN: UZ Leuven ;
Condition / Disease: PTH non-dependant hypercalcemia
Publication: eBioMedicine v97 p104817 Year: 2023 ORPHAcode / other: ORPHA68415; ORPHA405;
DOI: 10.1016/j.ebiom.2023.104817 Keywords: Androgen deprivation therapy,Androgen receptor signalling inhibitor,Bone turnover marker,Prostate cancer,Stable calcium isotope
MTG2

A Prospective Multicenter Study Examining the Relationship Between Thyroid Cancer Treatment Outcomes and the Presence of Autoimmune Thyroiditis


Author(s): De Leo S, D'Elia S, Grani G, Dondi F, Bertagna F, Puxeddu E, Morelli S, Piovesan A, Nervo A, Zatelli MC, Gagliardi I, Samà MT, Aimaretti G, Crocetti U, Massa M, Deandrea M, Retta F, Pagano L, Rossi M, Solaroli E, Pezzullo L, Chiofalo MG, Pontecorvi A, Lombardi CP, Antonelli A, Patrizio A, Messuti I, Magri F, Spiazzi G, Ceresini G, Bruno R, Sparano C, Centanni M, Crescenzi A, Tallini G, Marotta V, Madeo B, Mian C, Filetti S, Durante C, Fugazzola L
Affiliated Institution / ERN: AOU - Ferrara ; University Hospital of Padova ; AOU-Bologna ;
Condition / Disease: Oncogenic osteomalacia
Publication: Thyroid® v33.11 p1318-1326 Year: 2023 ORPHAcode / other: ORPH352540
DOI: 10.1089/thy.2023.0052 Keywords: outcome,prospective,radioiodine,thyroid cancer,thyroiditis
MTG2

Resumen ejecutivo del documento de consenso de expertos de la Sociedad Española de Neurocirugía y de la Sociedad Española de Endocrinología y Nutrición sobre: recomendaciones clínicas en el manejo perioperatorio de los tumores hipofisarios


Author(s): Araujo-Castro M, Rodríguez-Berrocal V, Dios E, Serramito R, Biagetti B, Bernabeu I
Affiliated Institution / ERN:
Condition / Disease: Pituitary adenomas
Publication: Endocrinología, Diabetes y Nutrición v70.9 p592-608 Year: 2023 ORPHAcode / other: ORPHA99408
DOI: 10.1016/j.endinu.2023.06.004 Keywords:
MTG6

Historical perspectives of glucagon’s discovery and early research


Author(s): Brahmachari D, Masood SN, Aziz U, Milenkovic T, Chawla M, Unnikrishnan AG, Ghosh S, Raposo J, Saboo B, Mohan V
Affiliated Institution / ERN: APDP – Diabetes Portugal ;
Condition / Disease: Glucagon
Publication: Journal of Diabetology v14.Supplement 1 pS8-S10 Year: 2023 ORPHAcode / other:
DOI: 10.4103/jod.jod_107_23 Keywords: Diabetes, endocrinology, glucagon, glucose homeostasis, historical research, hormone discovery, insulin, pancreatic hormones, therapeutic applications
MTG3

Executive summary of the expert consensus document from the Spanish Society of Neurosurgery and the Spanish Society of Endocrinology and Nutrition: clinical recommendations on the perioperative management of pituitary tumors


Author(s): Araujo-Castro M, Berrocal VR, Dios E, Serramito R, Biagetti B, Bernabeu I
Affiliated Institution / ERN: Hospital Universitari Vall d’Hebron ;
Condition / Disease: Pituitary adenomas
Publication: Neurocirugía (English Edition) v34.6 p292-307 Year: 2023 ORPHAcode / other: ORPHA99408
DOI: 10.1016/j.neucie.2023.07.007 Keywords: Acromegalia,Acromegaly,Adenoma hipofisario no funcionante,Cirugía transesfenoidal,Cushing’s disease,Diabetes insipidus,Diabetes insípida,Déficit de vasopresina,Enfermedad de cushing,Hiponatremia,Hyponatremia,Non-functioning pituitary tumor,PITNET,Pituitary tumor,SIADH,Transsphenoidal surgery,Tumor hipofisario,Vasopressin deficiency
MTG6

Incidental versus symptomatic nonfunctioning pituitary adenomas: Are they different?


Author(s): Guerreiro V, Mendonça F, Urbano Ferreira H, Freitas P, Pereira J, Bernardes I, Pinheiro J, Guimarães T, Carvalho D
Affiliated Institution / ERN: Unidade Local de Saúde de Santa Maria(ULS de Santa Maria) ;
Condition / Disease: Pituitary adenoma
Publication: Endocrinology, Diabetes & Metabolism v6.6 Year: 2023 ORPHAcode / other: ORPHA99408
DOI: 10.1002/edm2.445 Keywords: adenomas,hypopituitarism,nonfunctioning,pituitary
MTG6

Loss of phospholipase PLAAT3 causes a mixed lipodystrophic and neurological syndrome due to impaired PPARγ signaling


Author(s): Schuermans N, El Chehadeh S, Hemelsoet D, Gautheron J, Vantyghem M, Nouioua S, Tazir M, Vigouroux C, Auclair M, Bogaert E, Dufour S, Okawa F, Hilbert P, Van Doninck N, Taquet M, Rosseel T, De Clercq G, Debackere E, Van Haverbeke C, Cherif FR, Urtizberea JA, Chanson J, Funalot B, Authier F, Kaya S, Terryn W, Callens S, Depypere B, Van Dorpe J, Vanlander AV, Verloo P, Coucke PJ, Poppe B, Impens F, Mizushima N, Depienne C, Jéru I, Dermaut B
Affiliated Institution / ERN: Assistance Publique-Hôpitaux de Paris, Hôpital Pitié-Salpétrière ;
Condition / Disease: Genetic lipodystrophy
Publication: Nature Genetics v55.11 p1929-1940 Year: 2023 ORPHAcode / other: ORPHA98305
DOI: 10.1038/s41588-023-01535-3 Keywords:
MTG3

Combination of osteogenesis imperfecta and hypophosphatasia in three children with multiple fractures, low bone mass and severe osteomalacia, a challenge for therapeutic management


Author(s): Fratzl-Zelman N, Linglart A, Bin K, Rauch F, Blouin S, Coutant R, Donzeau A
Affiliated Institution / ERN: CHU d'Angers ; Hôpital Bicêtre ;
Condition / Disease: osteogenesis imperfecta, hypophosphatasia
Publication: European Journal of Medical Genetics v66.11 p104856 Year: 2023 ORPHAcode / other: ORPHA436; ORPHA666;
DOI: 10.1016/j.ejmg.2023.104856 Keywords: Bone biopsy samples,Bone histomorphometry,Mineralization,Quantitative backscattered electron microscopy,Rare bone disorders,Therapy
MTG5

Pituitary macroadenomas in childhood and adolescence: a clinical analysis of 7 patients


Author(s): Aguilar-Riera C, Clemente M, González-Llorens N, Mogas E, Campos-Martorell A, Fàbregas A, Biagetti B, Vázquez E, Yeste D
Affiliated Institution / ERN: Hospital Universitari Vall d’Hebron ;
Condition / Disease: pituitary adenoma
Publication: Clinical Diabetes and Endocrinology v9.1 Year: 2023 ORPHAcode / other: ORPHA99408
DOI: 10.1186/s40842-023-00153-6 Keywords: Adolescent,Cabergoline,Child,Genetic analysis,Macroadenoma,Transsphenoidal
MTG6

XLH Matters 2022: Insights and recommendations to improve outcomes for people living with X-linked hypophosphataemia (XLH)


Author(s): Seefried L, Alzahrani A, Arango Sancho P, Bacchetta J, Crowley R, Emma F, Gibbins J, Grandone A, Javaid MK, Mindler G, Raimann A, Rothenbuhler A, Tucker I, Zeitlin L, Linglart A
Affiliated Institution / ERN: Hôpital Bicêtre ; AOU University of Campania "Luigi Vanvitelli", Naples ;
Condition / Disease: XLH
Publication: Orphanet Journal of Rare Diseases v18.S2 Year: 2023 ORPHAcode / other: ORPHA89936
DOI: 10.1186/s13023-023-02883-3 Keywords:
MTG2

Perinatally diagnosed congenital craniopharyngiomas in the KRANIOPHARYNGEOM trials


Author(s): Beckhaus J, Boekhoff S, Scheinemann K, Schilling FH, Fleischhack G, Binder G, Bison B, Pietsch T, Friedrich C, Müller HL
Affiliated Institution / ERN: Universitätsklinikum Tübingen ;
Condition / Disease: craniopharyngioma
Publication: Endocrine Connections v12.12 Year: 2023 ORPHAcode / other: ORPHA54595
DOI: 10.1530/ec-23-0294 Keywords: congenital,craniopharyngioma,irradiation,neurosurgery,quality of life
MTG6

Perinatal asphyxia and hypothermic treatment from the endocrine perspective


Author(s): Improda N, Capalbo D, Poloniato A, Garbetta G, Dituri F, Penta L, Aversa T, Sessa L, Vierucci F, Cozzolino M, Vigone MC, Tronconi GM, del Pistoia M, Lucaccioni L, Tuli G, Munarin J, Tessaris D, de Sanctis L, Salerno M
Affiliated Institution / ERN: San Raffaele hospital - Milan ;
Condition / Disease: Perinatal asphyxia and hypothermic treatment
Publication: Frontiers in Endocrinology v14 Year: 2023 ORPHAcode / other:
DOI: 10.3389/fendo.2023.1249700 Keywords: electrolytes disturbances,endocrine sequelae,glucose abnormalities,hypothermic treatment,perinatal asphyxia,stress adaptations
MTG2 MTG3

Editorial: Thyroid nodules and tumors in childhood


Author(s): de Sanctis L, Wasniewska M, Vigone MC
Affiliated Institution / ERN: San Raffaele hospital - Milan ;
Condition / Disease: Thyroid cancer
Publication: Frontiers in Endocrinology v14 Year: 2023 ORPHAcode / other: ORPHA146
DOI: 10.3389/fendo.2023.1303749 Keywords: ACR-TIRADS,EU-TIRADS,FNAB,del22q11 syndrome,phosphatase and tensin homolog deleted on chromosome 10 (PTEN),thyroid cancer,thyroid nodules,thyroiditis
MTG8

Neonatal and Early Infancy Features of Patients With Inactivating PTH/PTHrP Signaling Disorders/Pseudohypoparathyroidism


Author(s): Del Sindaco G, Berkenou J, Pagnano A, Rothenbuhler A, Arosio M, Mantovani G, Linglart A
Affiliated Institution / ERN: Hôpital Bicêtre ; Foundation IRCCS CA'Granda Ospedale Maggiore polyclinic - Milan ;
Condition / Disease: Inactivating PTH,PTHrP Signaling Disorders,Pseudohypoparathyroidism
Publication: The Journal of Clinical Endocrinology & Metabolism v108.11 p2961-2969 Year: 2023 ORPHAcode / other: ORPHA97593
DOI: 10.1210/clinem/dgad236 Keywords: ectopic ossifications,infancy,neonatal complications,newborns,pseudohypoparathyroidism
MTG2

Impact of Newborn Screening on Adult Height in Patients With Congenital Adrenal Hyperplasia (CAH)


Author(s): Hoyer-Kuhn H, Eckert AJ, Binder G, Bonfig W, Dübbers A, Riedl S, Woelfle J, Dörr HG, Holl RW
Affiliated Institution / ERN: Universitätsklinikum Tübingen ; Klinikum Wels Grieskirchen ;
Condition / Disease: Congenital Adrenal Hyperplasia
Publication: The Journal of Clinical Endocrinology & Metabolism v108.11 pe1199-e1204 Year: 2023 ORPHAcode / other: ORPHA418
DOI: 10.1210/clinem/dgad307 Keywords: CYP21A2,congenital adrenal hyperplasia,near adult height,newborn screening
MTG1

Comorbidities in mild autonomous cortisol secretion and the effect of treatment: systematic review and meta-analysis


Author(s): Pelsma ICM, Fassnacht M, Tsagarakis S, Terzolo M, Tabarin A, Sahdev A, Newell-Price J, Marina L, Lorenz K, Bancos I, Arlt W, Dekkers OM
Affiliated Institution / ERN: Evangelismos General Hospital ;
Condition / Disease: Cushing syndrome
Publication: European Journal of Endocrinology v189.4 pS88-S101 Year: 2023 ORPHAcode / other: ORPHA647758; ORPHA189427; ORPHA314749;
DOI: 10.1093/ejendo/lvad134 Keywords: adrenal adenoma,comorbidities,cortisol,mild autonomous cortisol secretion,systematic review
MTG1

Hormonal control during infancy and testicular adrenal rest tumor development in males with congenital adrenal hyperplasia: a retrospective multicenter cohort study


Author(s): Schröder MAM, Neacşu M, Adriaansen BPH, Sweep FCGJ, Ahmed SF, Ali SR, Bachega TASS, Baronio F, Birkebæk NH, de Bruin C, Bonfig W, Bryce J, Clemente M, Cools M, Elsedfy H, Globa E, Guran T, Güven A, Amr NH, Janus D, Taube NL, Markosyan R, Miranda M, Poyrazoğlu Å, Rees A, Salerno M, Stancampiano MR, Vieites A, de Vries L, Yavas Abali Z, Span PN, Claahsen-van der Grinten HL
Affiliated Institution / ERN: Klinikum Wels Grieskirchen ; Aarhus University Hospital ; AOU Federico II - Naples ; Radboud University Medical Centre Nijmegen ; AOU-Bologna ;
Condition / Disease: Congenital adrenal hyperplasia
Publication: European Journal of Endocrinology v189.4 p460-468 Year: 2023 ORPHAcode / other: ORPHA418
DOI: 10.1093/ejendo/lvad143 Keywords: congenital adrenal hyperplasia,diagnosis,early childhood,testicular adrenal rest tumors
MTG1

Therapeutic Management and Long-Term Outcome of Hyperthyroidism in Patients with Antithyroid-Induced Agranulocytosis: A Retrospective, Multicenter Study


Author(s): García Gómez C, Navarro E, Alcázar V, López-Guzmán A, Arrieta F, Anda E, Biagetti B, Guerrero-Pérez F, Villabona C, de Assín Valverde AR, Lamas C, Lecumberri B, Rosado Sierra JA, Sastre J, Díez JJ, Iglesias P
Affiliated Institution / ERN: Hospital Universitari Vall d’Hebron ;
Condition / Disease: Antithyroid-Induced Agranulocytosis, Hyperthyroidism
Publication: Journal of Clinical Medicine v12.20 p6556 Year: 2023 ORPHAcode / other:
DOI: 10.3390/jcm12206556 Keywords: antithyroid drug-induced agranulocytosis (AIA),carbimazole (CBZ),methimazole (MMI),propylthiouracil (PTU)
MTG8

Gender-related differences in patients with carcinoid syndrome: new insights from an Italian multicenter cohort study


Author(s): Ruggeri RM, Altieri B, Razzore P, Retta F, Sperti E, Scotto G, Brizzi MP, Zumstein L, Pia A, Lania A, Lavezzi E, Nappo G, Laffi A, Albertelli M, Boschetti M, Hasballa I, Veresani A, Prinzi N, Pusceddu S, Oldani S, Nichetti F, Modica R, Minotta R, Liccardi A, Cannavale G, Grossrubatscher EM, Tarsitano MG, Zamponi V, Zatelli MC, Zanata I, Mazzilli R, Appetecchia M, Davì MV, Guarnotta V, Giannetta E, La Salvia A, Fanciulli G, Malandrino P, Isidori AM, Colao A, Faggiano A
Affiliated Institution / ERN: AOU Federico II - Naples ; AOU polyclinic "G.Martino" of Messina ; IRCCS Ospedale Policlinico San Martino – Genova ; AOU Policlinico Umberto I - Rome ; AOU - Ferrara ;
Condition / Disease: Hereditary pheochromocytoma-paraganglioma
Publication: Journal of Endocrinological Investigation v47.4 p959-971 Year: 2023 ORPHAcode / other: ORPHA29072
DOI: 10.1007/s40618-023-02213-1 Keywords: Carcinoid syndrome,Gender,Gender medicine,Neuroendocrine neoplasm,Neuroendocrine tumors,Prognosis,Sex
MTG4

Long-term efficacy and safety of subcutaneous pasireotide alone or in combination with cabergoline in Cushing’s disease


Author(s): Feelders RA, Fleseriu M, Kadioglu P, Bex M, González-Devia D, Boguszewski CL, Yavuz DG, Patino H, Pedroncelli AM, Maamari R, Chattopadhyay A, Biller BMK, Pivonello R
Affiliated Institution / ERN: AOU Federico II - Naples ;
Condition / Disease: Cushing's disease
Publication: Frontiers in Endocrinology v14 Year: 2023 ORPHAcode / other: ORPHA96253
DOI: 10.3389/fendo.2023.1165681 Keywords: Cushing’s disease,cabergoline,hypercortisolism,pasireotide,somatostatin
MTG6

The use of precision diagnostics for monogenic diabetes: a systematic review and expert opinion


Author(s): Murphy R, Colclough K, Pollin TI, Ikle JM, Svalastoga P, Maloney KA, Saint-Martin C, Molnes J, Tobias DK, Merino J, Ahmad A, Aiken C, Benham JL, Bodhini D, Clark AL, Colclough K, Corcoy R, Cromer SJ, Duan D, Felton JL, Francis EC, Gillard P, Gingras V, Gaillard R, Haider E, Hughes A, Ikle JM, Jacobsen LM, Kahkoska AR, Kettunen JLT, Kreienkamp RJ, Lim L, Männistö JME, Massey R, Mclennan N, Miller RG, Morieri ML, Most J, Naylor RN, Ozkan B, Patel KA, Pilla SJ, Prystupa K, Raghaven S, Rooney MR, Schön M, Semnani-Azad Z, Sevilla-Gonzalez M, Takele WW, Tam CH, Thuesen ACB, Tosur M, Wallace AS, Wang CC, Wong JJ, Yamamoto JM, Young K, Amouyal C, Andersen MK, Bonham MP, Chen M, Cheng F, Chikowore T, Chivers SC, Clemmensen C, Dabelea D, Dawed AY, Deutsch AJ, Dickens LT, DiMeglio LA, Dudenhöffer-Pfeifer M, Evans-Molina C, Fernández-Balsells MM, Fitipaldi H, Fitzpatrick SL, Gitelman SE, Goodarzi MO, Grieger JA, Guasch-Ferré M, Habibi N, Hansen T, Huang C, Harris-Kawano A, Ismail HM, Hoag B, Johnson RK, Jones AG, Koivula RW, Leong A, Leung GKW, Libman IM, Liu K, Long SA, Lowe WL, Morton RW, Motala AA, Onengut-Gumuscu S, Pankow JS, Pathirana M, Pazmino S, Perez D, Petrie JR, Powe CE, Quinteros A, Jain R, Ray D, Ried-Larsen M, Saeed Z, Santhakumar V, Kanbour S, Sarkar S, Monaco GSF, Scholtens DM, Selvin E, Sheu WH, Speake C, Stanislawski MA, Steenackers N, Steck AK, Stefan N, Støy J, Taylor R, Tye SC, Ukke GG, Urazbayeva M, Van der Schueren B, Vatier C, Wentworth JM, Hannah W, White SL, Yu G, Zhang Y, Zhou SJ, Beltrand J, Polak M, de Franco E, Flanagan SE, Maloney KA, McGovern A, Nakabuye M, Njølstad PR, Pomares-Millan H, Provenzano M, Zhang C, Zhu Y, Auh S, de Souza R, Fawcett AJ, Gruber C, Mekonnen EG, Mixter E, Sherifali D, Eckel RH, Nolan JJ, Philipson LH, Brown RJ, Billings LK, Boyle K, Costacou T, Dennis JM, Florez JC, Gloyn AL, Gomez MF, Gottlieb PA, Greeley SAW, Griffin K, Hattersley AT, Hirsch IB, Hivert M, Hood KK, Josefson JL, Kwak SH, Laffel LM, Lim SS, Loos RJF, Ma RCW, Mathieu C, Mathioudakis N, Meigs JB, Misra S, Mohan V, Murphy R, Oram R, Owen KR, Ozanne SE, Pearson ER, Perng W, Pollin TI, Pop-Busui R, Pratley RE, Redman LM, Redondo MJ, Reynolds RM, Semple RK, Sherr JL, Sims EK, Sweeting A, Tuomi T, Udler MS, Vesco KK, Vilsbøll T, Wagner R, Rich SS, Franks PW, Misra S, Aukrust I, de Franco E, Flanagan SE, Njølstad PR, Billings LK, Owen KR, Gloyn AL
Affiliated Institution / ERN: Assistance Publique-Hôpitaux de Paris, Hôpital Pitié-Salpétrière ;
Condition / Disease: monogenic diabetes
Publication: Communications Medicine v3.1 Year: 2023 ORPHAcode / other: ORPHA552
DOI: 10.1038/s43856-023-00369-8 Keywords:
MTG3

The highly and perpetually upregulated thyroglobulin gene is a hallmark of functional thyrocytes


Author(s): Ullrich S, Leidescher S, Feodorova Y, Thanisch K, Fini J, Kaspers B, Weber F, Markova B, Führer D, Romitti M, Krebs S, Blum H, Leonhardt H, Costagliola S, Heuer H, Solovei I
Affiliated Institution / ERN: University Hospital Essen ;
Condition / Disease: thyroglobulin gene
Publication: Frontiers in Cell and Developmental Biology v11 Year: 2023 ORPHAcode / other:
DOI: 10.3389/fcell.2023.1265407 Keywords: gene upregulation,thyroglobulin gene,thyroid hormones,transcription,transcription loop
MTG8

Application of calcium-to-phosphorus (Ca/P) ratio in the diagnosis of pseudohypoparathyroidism: another piece in the puzzle of diagnosis of Ca-P metabolism disorders


Author(s): De Vincentis S, Del Sindaco G, Pagnano A, Brigante G, Moretti A, Zirilli L, Rochira V, Simoni M, Mantovani G, Madeo B
Affiliated Institution / ERN: Foundation IRCCS CA'Granda Ospedale Maggiore polyclinic - Milan ;
Condition / Disease: Inactivating PTH/PTHrP Signaling Disorders/Pseudohypoparathyroidism
Publication: Frontiers in Endocrinology v14 Year: 2023 ORPHAcode / other: ORPHA97593
DOI: 10.3389/fendo.2023.1268704 Keywords: hyperphosphatemia,hypocalcemia,hypoparathyroidism,mineral disorders,parathyroid dysfunctions
MTG2
Page 6 of 30« First«...45678...2030...»Last »

Endo-ERN Newsletter

Subscribe to our newsletter to receive updates on all network activities and new resources. As soon as you subscribe you will receive an email asking you to confirm your registration.

SIGN UP NOW

News

  • All news
  • Newsletter signup

Events

  • Upcoming events
  • Webinars

Information

  • About Us
  • Contact
  • FAQs

Social Links

Linkedin Facebook Youtube

Contact

Endo-ERN
Coordinating Center
Meibergdreef 9
1105 AZ AMSTERDAM
The Netherlands

info@endo-ern.eu
Funded by the European Union
©2025. All Rights Reserved. Endo-ERN

Privacy Policy – GDPR

Website design by Elan Creative

We are using cookies to give you the best experience on our website.

You can find out more about which cookies we are using or switch them off in .

Information video for patients and healthcare professionals

Type and Press “enter” to Search

Search
Privacy Overview
Endo-ERN

Endo-ERN Privacy Policy

Endo-ERN is committed to user’s privacy and does not track personal data when visiting our website. We act in accordance with Regulation 2016/679 of the European Parliament and of the Council.

‘Personal data’ means any information relating to an identified or identifiable natural person. An identifiable natural person is one who can be identified, directly or indirectly, in particular by reference to an identifier such as:

  • a name
  • an identification number
  • location data
  • an online identifier or to one or more factors specific to the physical, physiological, genetic, mental, economic, cultural or social identity of that natural person

Cookies

Endo-ERN only tracks anonymised data for statistical purposes. We do this via analytical cookies, placed through an anonymous IP Google analytics tag. The purpose of these cookies are to track the efficiency and success of the website.

These cookies do not store any personal data that can be linked to a natural person, but may save data such as inter alia, data about the website from which a person has come (the so-called referrer), which sub-pages were visited, or how often and for what duration a sub-page was viewed. The data collected through this is general data only, and cannot be traced back to one person.

It is possible to prevent the setting of cookies, by means of a setting of the Internet browser used. On top of that, already set cookies may be deleted at any time via an Internet browser or other software programs. This is possible in all popular Internet browsers.

Google Analytics does not share any data with third parties.

The principles of data protection do not apply to anonymous information and because these cookies minimally impact the privacy of the user, it is not necessary to ask for permission to use these cookies.

Newsletter

You may always unsubscribe from our newsletter at any time through the unsubscribe button located in our newsletter. Endo-ERN is both the controller and responsible for processing of any data regarding the newsletter. Endo-ERN does not make use of a third party for the Newsletter service.

E-services

Endo-ERN has a contact form, which activates your email software and allows you to send a comment or question to a general email address. When you send such a message, your personal data is collected only to the extent necessary to reply. If the team responsible for the mailbox is unable to answer your question, or your questions has regards to another party, it might forward your email to another service.

If you have any questions about the processing of your email and related personal data, do not hesitate to include them in your message.

The collected personal data and all information related to the above mentioned consultation is stored on the email server of the Endo-ERN Coordinating office and potentially those who have been concerned in the correspondence in order to respond to your comment.

Newsletter Tracking

The Endo-ERN newsletter makes use of tracking in order to be able to conduct a statistical analysis of the success or failure of online marketing campaigns. Endo-ERN may see if an email containing a newsletter was opened by a user, when it was opened, and which links were opened. 
The data collected through this tracking is generated and stored by Endo-ERN and is not shared with third parties, but may be used to adapt future content of newsletters in order to better meet the interests of our subscribers.

Contact details

For any questions regarding our privacy policy, please contact the Endo-ERN coordinating office.

You have the right to be forgotten and removed completely from the Endo-ERN contact database. To request this, please contact the Endo-ERN coordinating office.

Endo-ERN Coordinating Center, Meibergdreef 9, 1105 AZ  AMSTERDAM. The Netherlands

 info@endo-ern.eu
Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

Powered by  GDPR Cookie Compliance